Maureen Gannon

Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes. Read More

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes. Read More

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read More

Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee. Read More

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read More

New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read More

Vanderbilt researchers describe a new technique for identifying factors that stimulate the proliferation of pancreatic beta cells – factors that might offer therapeutic options for diabetes. Read More

The annual Southeast Regional meeting of the Society for Developmental Biology, hosted by Vanderbilt for the first time since 2006, broke participant records with 163 investigators registered and 81 posters presented. Read More

A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read More